-
,for, Item ID-
- #170899
- Covidien #8886628771
Absorbable Suture with Needle Maxon™ Polyglyconate GS -24 1/2 Circle Taper Point Needle Size 1-0 Monofilament
SUTURE, MAXON GRN 1 36" T-25 (36/BX)
Features
- MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
- MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
- MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
- More …
Product Details Email
Product Specifications
| McKesson # | 170899 |
|---|---|
| Manufacturer # | 8886628771 |
| Brand or Series | Maxon™ |
| Manufacturer Name | Covidien |
| Country of Origin | Unknown |
| Application | Absorbable Suture with Needle |
| Buy American Act (BAA) Compliant | No |
| Coating | Uncoated |
| Manufacturer Number | 8886628771 |
| Needle 1 Code | GS -24 |
| Needle Length | 40 mm |
| Needle Length Range | 20.1 to 40 mm |
| Needle Material | Alloy Needle |
| Needle Shape | 1/2 Circle |
| Needle Type | Taper Point Needle |
| Number of Needles | 1-Needle |
| Number of Strands | 36-Strand |
| Sterility | Sterile |
| Suture Color | Green |
| Suture Length | 36 Inch Suture |
| Suture Length Range | 20.1 to 40 in. |
| Suture Material | Polyglyconate |
| Suture Material Range | Dyed Synthetic |
| Suture Size | Size 1-0 |
| Suture Type | Monofilament |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 42312201 |
Features
- MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
- MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
- MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
- MAXON™ sutures retain approximately 75% of initial tensile strength at two weeks, 65% of at three weeks and 50% at four weeks post-implant
- Absorption of MAXON™ sutures is minimal until about 60 days after implant and is essentially complete within six months
- This product is required to be reported under California Proposition 65
More Information
Frequently Viewed Together
-
,for, Item ID-
- #1034499
- McKesson Brand #SG-122H
-
,for, Item ID-
- #217663
- J & J Healthcare Systems #Y416H
-
,for, Item ID-
- #217677
- J & J Healthcare Systems #Y417H
-
,for, Item ID-
- #501218
- Covidien #SMM-5526
-
,for, Item ID-
- #500655
- Covidien #SMM-5043
-
,for, Item ID-
- #506676
- Covidien #SMM-5044
-
,for, Item ID-
- #171686
- Covidien #8886661241
-
,for, Item ID-
- #312792
- Covidien #GM-322
-
,for, Item ID-
- #316224
- Covidien #GM-323
-
,for, Item ID-
- #504615
- Covidien #SMM-5536
-
,for, Item ID-
- #153411
- J & J Healthcare Systems #V402G
-
,for, Item ID-
- #171664
- Covidien #8886661231
-
,for, Item ID-
- #810208
- Covidien #GMM-344L
-
,for, Item ID-
- #316257
- Covidien #UM-214
-
,for, Item ID-
- #1175393
- Surgical Specialties #R346N
-
,for, Item ID-
- #309055
- Covidien #GM-321